Search research articles
Contact Us
Filters
Showing results (541-550 of 619) with videos related to
Page
of 62
Sort By:
Journal of Biomolecular Techniques : JBT
|
March 13, 2023
Commercial ChIP-Seq Library Preparation Kits Performed Differently for Different Classes of Protein Targets
M S Simper, L Della Coletta, S Gaddis, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 19, 2026
DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers
Fengzhi Li, Xiang Ling, Sayan Chakraborty, et al.
Hemoglobin
|
January 1, 1984
Hemoglobin Chongqing [alpha 2(NA2)Leu----Arg] and hemoglobin Harbin [alpha 16(A14)Lys----Met] found in China
Y T Zeng, S Z Huang, X K Qiu, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
August 25, 2011
Exercise blood pressure response during assisted circulatory support: comparison of the total artificial [corrected] heart with a left ventricular assist device during rehabilitation
Harajeshwar S Kohli, Justin Canada, Ross Arena, et al.
RNA Biology
|
October 1, 2021
Inhibition of CDK9 activity compromises global splicing in prostate cancer cells
Qiang Hu, Ninu Poulose, Samuel Girmay, et al.
Pathology Oncology Research : POR
|
October 8, 1998
BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases
D G Tang, L Li, Z Zhu, et al.
Plos One
|
September 22, 2011
Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms
Hong Yan, Xin Chen, Qiuping Zhang, et al.
Changgeng Yi Xue Za Zhi
|
December 16, 1998
Implications of a failed prospective trial of adjuvant therapy after radical hysterectomy for stage Ib-IIa cervical carcinoma with pelvic node metastases
C H Lai, S G Tang, T C Chang, et al.
International Journal of Laboratory Hematology
|
March 21, 2017
A multicenter study on PIVKA reference interval of healthy population and establishment of PIVKA cutoff value for hepatocellular carcinoma diagnosis in China
X Qin, G Tang, R Gao, et al.
Cancer Letters
|
September 1, 2024
Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy
Qinju He, Yuanzhen Zhang, Wenchao Li, et al.
Page
of 62
Search research articles
Search
Showing results (541-550 of 619) with videos related to
Sort By:
Page
of 62
Journal of Biomolecular Techniques : JBT
|
March 13, 2023
Commercial ChIP-Seq Library Preparation Kits Performed Differently for Different Classes of Protein Targets
M S Simper, L Della Coletta, S Gaddis, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 19, 2026
DDX5 (p68) and UbE2T as emerging superior cancer therapeutic targets: dual molecular glue target degradation by FL118 for conquering difficult-to-treat cancers
Fengzhi Li, Xiang Ling, Sayan Chakraborty, et al.
Hemoglobin
|
January 1, 1984
Hemoglobin Chongqing [alpha 2(NA2)Leu----Arg] and hemoglobin Harbin [alpha 16(A14)Lys----Met] found in China
Y T Zeng, S Z Huang, X K Qiu, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
August 25, 2011
Exercise blood pressure response during assisted circulatory support: comparison of the total artificial [corrected] heart with a left ventricular assist device during rehabilitation
Harajeshwar S Kohli, Justin Canada, Ross Arena, et al.
RNA Biology
|
October 1, 2021
Inhibition of CDK9 activity compromises global splicing in prostate cancer cells
Qiang Hu, Ninu Poulose, Samuel Girmay, et al.
Pathology Oncology Research : POR
|
October 8, 1998
BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases
D G Tang, L Li, Z Zhu, et al.
Plos One
|
September 22, 2011
Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms
Hong Yan, Xin Chen, Qiuping Zhang, et al.
Changgeng Yi Xue Za Zhi
|
December 16, 1998
Implications of a failed prospective trial of adjuvant therapy after radical hysterectomy for stage Ib-IIa cervical carcinoma with pelvic node metastases
C H Lai, S G Tang, T C Chang, et al.
International Journal of Laboratory Hematology
|
March 21, 2017
A multicenter study on PIVKA reference interval of healthy population and establishment of PIVKA cutoff value for hepatocellular carcinoma diagnosis in China
X Qin, G Tang, R Gao, et al.
Cancer Letters
|
September 1, 2024
Inhibition of PRMT5 moderately suppresses prostate cancer growth in vivo but enhances its response to immunotherapy
Qinju He, Yuanzhen Zhang, Wenchao Li, et al.
Page
of 62